Arcturus Therapeutics Holdings Inc. Common Stock
Symbol: ARCT (NASDAQ)
17.15
▼ (-4.96%) -0.895
Company Description:
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
Key Stats
- Today's Open: $17.65
- Today's High: $18.189
- Today's Low: $16.54
- Today's Volume: 644.25K
- Yesterday Close: $18.04
- Yesterday High: $18.6933
- Yesterday Low: $17.71
- Yesterday Volume: 572.36K
- Last Min Volume: 10
- Last Min High: $17.145
- Last Min Low: $17.145
- Last Min VWAP: $17.145
Company Profile
- Name: Arcturus Therapeutics Holdings Inc. Common Stock
- Website: https://www.arcturusrx.com
- Listed Date: 2013-05-22
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001768224
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $470.32M
- Round Lot: 100
- Outstanding Shares: 27.15M
- Asset Type: CS
RECENT FILINGS FOR ARCT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-29 | 8-K | View |
| 2025-08-20 | 4/A | View |
| 2025-08-19 | 4 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-30 | SCHEDULE 13G/A | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-06-30 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-06 | 8-K | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-04-25 | DEF 14A | View |
Latest News on ARCT